Antonios Fanouriakis

ScholarGPS® ID: 93587847426533

Affiliation

University of Crete, Rethymnon, Greece

Affiliation History

Field

Medicine

Discipline

Rheumatology

Top Specialties

Systemic Lupus Erythematosus | Lupus Erythematosus | Arthritis | Rheumatoid Arthritis

Metrics Summary

Publication Count

Predicted Citations

288

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series (conference) Flouda, Sofia \| Emmanouilidou, Evgenia \| Karamanakos, Anastasios \| Bertsias, George \| Boumpas, Dimitrios \| Fanouriakis, Antonios 14th European Lupus Meeting, Bruges, Belgium, March 19–22, 2024 (2024) 10.1136/lupus-2024-el.154 Cite \| Source
#6501 MULTICENTER STUDY ESTIMATING THE INCIDENCE OF ADVERSE EVENTS FROM SARS-CoV-2 VACCINATION AND ITS POTENTIAL EFFECT ON THE OUTCOME OF LUPUS NEPHRITIS (journal article) Lionaki, Sophia \| Petrou, Dimitra \| Flouda, Sophia \| Marinaki, Smaragdi \| Kriki, Pelagia \| Katartzi, Kostantia \| Venetsanopoulou, Aliki \| Voulgari, Paraskevi \| Agoranou, Marilena \| Gkiolas, Konstantinos \| ... \| Boletis, Ioannis Nephrology Dialysis Transplantation, volume 38, issue Supplement_1 (2023). 10.1093/ndt/gfad063c_6501 Cite \| Source
POS0786 UNMET TREATMENT NEEDS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A CROSS-SECTIONAL ASSESSMENT OF DISEASE ACTIVITY IN SLE PATIENTS DURING THEIR LAST VISIT (journal article) Gioti, O. \| Chavatza, K. \| Belevonis, G. \| Koutsoviti, S. \| Katsimpari, C. \| Sofianos, I. \| Tatsi, A. \| Tzanis, P. \| Lazarini, A. \| Klavdianou, K. \| ... \| Fanouriakis, A. Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 646.1-646 (2021). 10.1136/annrheumdis-2021-eular.3832 Cite \| Source
POS0759 THE JOURNEY OF PATIENTS FROM FIRST SYMPTOMS TO DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): AN OBSERVATIONAL STUDY (journal article) Kapsala, N. \| Flouda, S. \| Nikolopoulos, D. \| Chavatza, K. \| Pieta, A. \| Grivas, A. \| Ntourou, A. \| Togia, K. \| Rapsomaniki, P. \| Gerogianni, T. \| ... \| Boumpas, D. Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 632.2-633 (2021). 10.1136/annrheumdis-2021-eular.2975 Cited by (1) \| Cite \| Source
POS0757 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DIAGNOSED DURING HOSPITALIZATION: CLINICAL PHENOTYPE AND PERFORMANCE OF THE SLE RISK PROBABILITY INDEX (SLERPI) (journal article) Kapsala, N. \| Nikolopoulos, D. \| Flouda, S. \| Chavatza, K. \| Pieta, A. \| Grivas, A. \| Ntourou, A. \| Togia, K. \| Rapsomaniki, P. \| Gerogianni, T. \| ... \| Boumpas, D. Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 631-631 (2021). 10.1136/annrheumdis-2021-eular.2905 Cited by (1) \| Cite \| Source
OP0019 DEFINING SYSTEMIC LUPUS ERYTHEMATOSUS MOLECULAR TAXONOMY THROUGH DATA-DRIVEN RESTRATIFICATION AND IDENTIFICATION OF CLUSTER-TAILORED DRUGS FOR A PERSONALIZED MEDICINE APPROACH (journal article) Garantziotis, P. \| Nikolakis, D. \| Doumas, S. \| Fragou, E. \| Fanouriakis, A. \| Filia, A. \| Witte, T. \| Bertsias, G. \| Boumpas, D. Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 11.1-11 (2021). 10.1136/annrheumdis-2021-eular.1636 Cite \| Source
Response to the letter to the editor (journal article) Yavuz, Sule \| Bertsias, George \| Fanouriakis, Antonios Seminars in Arthritis and Rheumatism, volume 50, issue 6, pages e2- (2020). 10.1016/j.semarthrit.2020.09.011 Cite \| Source
FRI0155 Α MULTICENTER “AT-RISK” COHORT FOR THE DISCOVERY OF ENVIRONMENTAL, CLINICAL AND MOLECULAR PREDICTORS FOR THE TRANSITION INTO SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) (journal article) Adamichou, C. \| Nikolopoulos, D. \| Nikoloudaki, M. \| Rahme, Z. \| Fredi, M. \| Pieta, A. \| Repa, A. \| Parma, A. \| Kalogiannaki, E. \| Avgustidis, N. \| ... \| Bertsias, G. Annals of the Rheumatic Diseases, volume 79, issue Suppl 1, pages 661.1-661 (2020). 10.1136/annrheumdis-2020-eular.4468 Cite \| Source
FRI0170 THERAPEUTIC ΤARGETS AND QUALITY INDICATORS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), DEFINED ACCORDING TO THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS: DATA FROM THE “ATTIKON“ LUPUS COHORT (journal article) Havatza, K. \| Togia, K. \| Flouda, S. \| Pieta, A. \| Gioti, O. \| Nikolopoulos, D. \| Kapsala, N. \| Ntourou, A. \| Rapsomaniki, P. \| Gerogianni, T. \| ... \| Fanouriakis, A. Annals of the Rheumatic Diseases, volume 79, issue Suppl 1, pages 669.2-670 (2020). 10.1136/annrheumdis-2020-eular.6255 Cite \| Source
FRI0543 BIRTH REGISTRY OF WOMEN WITH SYSTEMATIC LUPUS ERYTHEMATOSUSAND COURSE OF THE DISEASE DURING FIRST YEARS POST-PARTUM-THE GREEK EXPERIENCE (journal article) Ntali, S. \| Pantazi, L. \| Boki, K. \| Nikolopoulos, D. \| Fanouriakis, A. \| Dimopoulou, D. \| Kallitsakis, I. \| Papagoras, C. \| Dania, V. \| Emmanouilidou, E. \| Bertsias, G. Annals of the Rheumatic Diseases, volume 79, issue Suppl 1, pages 872.2-873 (2020). 10.1136/annrheumdis-2020-eular.6195 Cite \| Source
Regional cerebral perfusion correlates with anxiety in neuropsychiatric SLE: evidence for a mechanism distinct from depression (journal article) Papadaki, E \| Kavroulakis, E \| Bertsias, G \| Fanouriakis, A \| Karageorgou, D \| Sidiropoulos, P \| Papastefanakis, E \| Boumpas, D T \| Simos, P Lupus, volume 28, issue 14, pages 1678-1689 (2019). 10.1177/0961203319887793 Cited by (17) \| Cite \| Source
THU0072 Gene signature of plasmacytoid dendritic cells reveals novel pathways contributing to tolerance in rheumatoid arthritis patients (conference) Papadaki, G. \| Goutakoli, P. \| Grün, J.R. \| Grützkau, A. \| Fanouriakis, A. \| Pavlopoulos, G.A. \| Iliopoulos, I. \| Bertsias, G. \| Boumpas, D. \| Sidiropoulos, P. \| Verginis, P. Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018 (2018) 10.1136/annrheumdis-2018-eular.5170 Cite \| Source
FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study (conference) Fanouriakis, A. \| Adamichou, C. \| Koutsoviti, S. \| Panopoulos, S. \| Staveri, C. \| Klagou, A. \| Tsalapaki, C. \| Pantazi, L. \| Konsta, S. \| Mavragani, C.P. \| ... \| Boumpas, D.T. Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018 (2018) 10.1136/annrheumdis-2018-eular.5259 Cite \| Source
SP0100 Neuropsychiatric lupus or not? (conference) Fanouriakis, A. Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018 (2018) 10.1136/annrheumdis-2018-eular.7726 Cite \| Source
AB0503 Therapeutic strategy and short-term outcome in neuropsychiatric systemic lupus erythematosus (conference) Bortoluzzi, A. \| Fanouriakis, A. \| Appenzeller, S. \| Carli, L. \| Carrara, G. \| Conti, F. \| Costallat, L. \| De Marchi, G. \| De Vita, S. \| Doria, A. \| ... \| Govoni, M. Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018 (2018) 10.1136/annrheumdis-2018-eular.6854 Cite \| Source
P009 Transcriptomic analysis of plasmacytoid dendritic cells from rheumatoid arthritis patients reveals novel targets for therapy (conference) Papadaki, G \| Goutakoli, P \| Grün, JR \| Grützkau, A \| Fanouriakis, A \| Pavlopoulos, GA \| Iliopoulos, I \| Bertsias, G \| Boumpas, D \| Sidiropoulos, P \| Verginis, P 38th European Workshop for Rheumatology Research, 22–24 February 2018, Geneva, Switzerland (2018) 10.1136/annrheumdis-2018-EWRR2018.35 Cite \| Source \| Open Access
FRI0236 After discontinuation of the 1st tumor necrosis factor inhibitor (TNFI), non-tnfi biologic agents have similar responses but higher survival compared to a 2nd course of a different tnfi: long-term prospective observational study of patients with r (conference) Flouri, ID \| Repa, A \| Avgoustidis, N \| Kougas, N \| Fanouriakis, A \| Papalopoulos, I \| Adamichou, C \| Kyfonidou, P \| Kampouraki, E \| Terizaki, M \| ... \| Sidiropoulos, P Annual European Congress of Rheumatology, 14–17 June, 2017 (2017) 10.1136/annrheumdis-2017-eular.6817 Cite \| Source
SAT0204 Abatacept survival in rheumatoid arthritis patients at 2 years is 59%; its use as a 2nd line biologic agent and lower baseline haq predict better survival in clinical practice: a prospective, observational single center study (conference) Flouri, ID \| Repa, A \| Avgoustidis, N \| Kougas, N \| Fanouriakis, A \| Papalopoulos, I \| Adamichou, C \| Kyfonidou, P \| Kampouraki, E \| Terizaki, M \| ... \| Sidiropoulos, P Annual European Congress of Rheumatology, 14–17 June, 2017 (2017) 10.1136/annrheumdis-2017-eular.6931 Cite \| Source
FRI0244 Low dose of rituximab is effective for maintenance of clinical remission or low disease activity in patients with rheumatoid arthritis (conference) Avgoustidis, N \| Flouri, I \| Adamichou, C \| Kabouraki, E \| Eskitzis, A \| Kyfonidou, P \| Papalopoulos, I \| Fanouriakis, A \| Repa, A \| Kougkas, N \| ... \| Sidiropoulos, P Annual European Congress of Rheumatology, 14–17 June, 2017 (2017) 10.1136/annrheumdis-2017-eular.4958 Cite \| Source
03.23 Transcriptomic analysis of plasmacytoid dendritic cells from rheumatoid arthritis patients reveals novel targets for therapy (conference) Papadaki, Garyfalia \| Goutakoli, Panagiota \| Grün, Joachim R \| Grützkau, Andreas \| Fanouriakis, Antonios \| Pavlopoulos, George A \| Iliopoulos, Ioannis \| Bertsias, George \| Boumpas, Dimitrios \| Sidiropoulos, Prodromos \| Verginis, Panayotis 37th European Workshop for Rheumatology Research 2–4 March 2017 Athens, Greece (2017) 10.1136/annrheumdis-2016-211049.23 Cite \| Source